犬疫苗市场报告：趋势、预测和竞争分析（至 2031 年）

未来全球犬疫苗市场很可能在兽医诊所和宠物饲主市场中看到机会。预计到 2031 年全球狗疫苗市场规模将达到 49 亿美元，2025 年至 2031 年的复合年增长率为 5.7%。这个市场的主要驱动力是宠物狗数量的增加、饲主对于为宠物狗进行预防性医疗保健的好处的认识不断提高、以及政府关于疫苗接种的法规。

• Lucintel 预测，由于犬类感染疾病发病率不断上升，且减毒活病毒疫苗将继续成为最大的细分市场。
• 在最终用途类别中，预计兽医医院和诊所将在预测期内实现高速成长。
• 从地区来看，北美可能仍是最大的地区，因为政府对疫苗接种有着严格的规定，以保护狗免受严重疾病的侵害并保护人类免受狗咬伤。

犬疫苗市场的策略性成长机会

由于技术的进步、宠物拥有率的提高和疫苗宣传活动的扩大，狗疫苗市场在关键应用领域呈现出多种策略成长机会。

• 扩展到新兴市场：将犬类疫苗接种计画扩展到新兴市场具有巨大的成长潜力。这样，他们就可以实现更好的取得和负担能力，占领更多的市场占有率，并减轻狗的疾病负担。
• 开发多效价疫苗：投资针对不同疾病的多效价疫苗可以简化疫苗接种过程并提高依从性。
• 更好的疫苗製剂：开发不太可能引起副作用并提供更长时间免疫的新型疫苗製剂具有优势。利用这些进步可以帮助提高人们对狗疫苗接种的接受度和吸收率。
• 整合数位健康平台：将数位健康平台整合到疫苗分发和追踪中可以提高疫苗接种率并改善宠物的整体健康状况。透过这些平台，您可以改善预约安排和库存管理。
• 创新的疫苗接种方法：开发创新的疫苗接种方法，例如口服疫苗，可以让饲主更容易接种疫苗。这代表着因疫苗接种增加而机会。

这些机会正在推动与犬疫苗产业相关的公共卫生领域的变革，改善疫苗取得途径并推动疫苗技术。

犬疫苗市场驱动因素与挑战

技术进步、经济因素和监管考量是影响犬疫苗市场的一些驱动因素和挑战。因此，了解这些因素对于了解市场格局至关重要。

推动犬疫苗市场发展的因素有：

• 宠物拥有量的增加：全球宠物数量的不断增长是狗疫苗需求的主要驱动力。随着越来越多的家庭拥有宠物，包括疫苗接种在内的预防性护理的需求正在推动市场成长。
• 技术进步：疫苗技术的改进，例如多效价疫苗和口服给药选择，进一步增加了需求。这些发展使得疫苗更加有效和方便，确保了疫苗接种的增加。
• 政府宣传活动：政府主导的疫苗宣传活动，尤其是在新兴国家，正在推动狗疫苗的销售。这些宣传活动有助于控制狂犬病等疾病并促进市场扩张。
• 扩大兽医基础设施：兽医服务和设施的扩大，特别是在新兴市场，为犬类疫苗的接种提供了更多管道。兽医基础设施的改善使更多的宠物能够及时接种疫苗，从而支持了整体市场的成长。

犬疫苗市场面临的挑战是：

• 经济限制：经济限制：疫苗生产成本及其定价等经济问题可能会导致该细分市场的波动。在扩张的过程中，实现成本和品质之间的平衡对于保持竞争力至关重要。
• 监管障碍：遵守严格的疫苗核准和安全法规是一项挑战。满足这些要求对于进入目标市场和开发产品至关重要，但它会减慢进程并增加成本。
• 疫苗接种不愿意：饲主不愿意接种疫苗是该行业发展的一大限制因素。解决对疫苗安全性和有效性的担忧可以显着提高疫苗接种率并扩大整体市场。

这些市场驱动因素和挑战透过决定产品开发、市场范围和法规遵循来塑造犬疫苗市场。

目录

第一章执行摘要

第 2 章。

• 简介、背景和分类
• 供应链
• 产业驱动因素与挑战

第 3 章 市场趋势与预测分析（2019-2031）

• 宏观经济趋势（2019-2024）与预测（2025-2031）
• 全球犬疫苗市场趋势（2019-2024 年）及预测（2025-2031 年）
• 全球犬类疫苗市场类型
  • 减毒活病毒疫苗
  • 结合疫苗
  • 灭活疫苗
  • 次单位疫苗
  • 类毒素疫苗
  • DNA疫苗
  • 重组疫苗
• 全球犬类疫苗市场（依年龄划分）
  • 少于 6 个月
  • 6个月或以上
• 全球犬类疫苗市场（依最终用途划分）
  • 兽医诊所
  • 宠物饲主
  • 其他的

第 4 章区域市场趋势与预测分析（2019-2031 年）

• 全球犬疫苗市场（按地区）
• 北美犬类疫苗市场
• 欧洲犬类疫苗市场
• 亚太犬类疫苗市场
• 世界其他地区犬类疫苗市场

第五章 竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 全球犬疫苗市场成长机会（按类型）
  • 全球犬疫苗市场按年龄分類的成长机会
  • 全球犬疫苗市场成长机会（依最终用途划分）
  • 全球犬疫苗市场成长机会（按地区）
• 全球犬疫苗市场的新趋势
• 战略分析
  • 新产品开发
  • 全球犬疫苗市场产能扩大
  • 全球犬疫苗市场的企业合併
  • 认证和许可

第七章主要企业简介

• Bayer
• Vetquinol
• Boehringer Ingelhiem
• Ceva
• Eli Lilly
• Heska
• Merck

The future of the global dog vaccine market looks promising with opportunities in the veterinary hospital & clinic and pet owner markets. The global dog vaccine market is expected to reach an estimated $4.9 billion by 2031 with a CAGR of 5.7% from 2025 to 2031. The major drivers for this market are the increasing adoption of pet dogs, growing awareness among pet owners about the benefits of preventive healthcare for their dogs, and government regulations for vaccinations.

• Lucintel forecasts that, within the type category, attenuated live will remain the largest segment due to the rising incidence of infectious diseases among dogs, as well as the convenience and effectiveness of this vaccine compared to others.
• Within the end-use category, veterinary hospitals & clinics are expected to witness higher growth over the forecast period.
• In terms of regions, North America will remain the largest region due to strict government regulations regarding vaccination to protect dogs from serious diseases, as well as to protect human life from dog biting.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Dog Vaccine Market

Dog vaccines are significantly changing due to evolving consumer tastes, technological developments, and increased awareness of dog health. The demand for innovative and efficient vaccines is rising as the incidence of pet ownership continues to increase globally. Several trends will shape the market and influence the development, distribution, and administration of vaccines.

• Manifold Vaccines: The trend toward manifold vaccines that protect dogs from numerous diseases with just one injection is growing. This simplifies the vaccination process, enhances compliance, and reduces stress for both dogs and owners.
• Digital Health Platforms: The integration of digital health platforms has revolutionized vaccine distribution and tracking. These platforms improve inventory management, appointment scheduling, and follow-up reminders, thereby increasing vaccination rates and overall pet health.
• Global Expansion of Pet Ownership: The rise in pet ownership in emerging markets is driving increased demand for dog vaccines. More households are acquiring pets in nations such as China and India, resulting in an expanding market for vaccines and increased production and distribution.
• Focus on Vaccine Safety and Efficacy: Attention is rising regarding the safety and effectiveness of dog vaccines. More stringent regulations have been established by regulatory bodies to ensure that these products are not only safe for pets but also effective in preventing diseases.
• Innovative Vaccine Delivery Methods: Oral vaccines and other novel delivery techniques are gaining popularity. These methods make it easier for pet owners to vaccinate their animals, thereby reducing the anxiety often associated with injectable vaccines.

These trends are reshaping the dog vaccine market by enhancing vaccine technology, expanding access, and improving overall pet health.

Recent Developments in the Dog Vaccine Market

The dog vaccine market is experiencing several key developments that spur growth and innovation in canine healthcare.

• Development of Multi-Valent Vaccines: Companies are introducing multi-valent vaccines that prevent various diseases with one shot. This makes the vaccination process easier and achieves higher compliance among pet owners.
• Expansion of Vaccine Access in Emerging Markets: Ongoing efforts aim to expand access to dog vaccines in emerging markets. This expansion is fueled by increased pet ownership and government initiatives aimed at controlling diseases like rabies.
• Advancements in Vaccine Formulations: Recent advances in vaccine formulations have resulted in more effective vaccines with fewer side effects. These improvements enhance vaccine performance and increase acceptance among pet owners.
• Integration of Digital Health Platforms: Vaccination rates are improving through the adoption of digital health platforms for vaccine distribution and tracking. These platforms facilitate better inventory management, appointment scheduling, and follow-up reminders.
• Innovation in Vaccine Delivery Methods: New vaccine delivery methods, such as oral vaccines, are being developed to simplify the process of vaccinating dogs. These innovations will increase vaccine uptake and improve overall pet health.

By enhancing vaccine technology, increasing access, and improving overall pet health, these developments propel the dog vaccine market forward.

Strategic Growth Opportunities for Dog Vaccine Market

The dog vaccine market presents several strategic opportunities for growth across major applications due to technological improvements, rising pet ownership, and expanding immunization campaigns.

• Emerging Markets Expansion: There is significant potential for growth in extending dog vaccination programs to emerging markets. By doing so, better access and affordability can be achieved, capturing more market share and reducing the canine disease burden.
• Development of Multi-Valent Vaccines: Investing in multi-valent vaccines that target various diseases can simplify the vaccination process and boost adherence, offering additional revenue opportunities by increasing attractiveness to buyers.
• Better Vaccine Formulations: The creation of new vaccine formulations that are less likely to cause side effects while providing longer immunity has its advantages. Utilizing these advancements can encourage the acceptance and use of dog vaccinations.
• Digital Health Platform Integration: Integrating digital health platforms into vaccine distribution and tracking leads to improved vaccination rates and enhances pets' overall health. Improved appointment scheduling and inventory management can be facilitated through these platforms.
• Innovative Methods of Vaccine Delivery: Developing innovative methods of vaccine delivery, such as oral vaccines, makes vaccination easier for owners. This represents an opportunity for growth through increased vaccine uptake.

These opportunities are driving changes in access improvements and advancing vaccine technology within the public health sector related to the dog vaccine industry.

Dog Vaccine Market Driver and Challenges

Technological advancements, economic factors, and regulatory considerations are among the drivers and challenges influencing the dog vaccine market. Therefore, it is essential to understand these elements to navigate the market landscape.

The factors driving the dog vaccine market include:

• Increased Number of Pet Owners: The global rise in pet ownership is a significant force behind the demand for dog vaccines. As more families keep pets, they require preventive care, including vaccinations, fostering market growth.
• Technological Advances: Improvements in vaccine technology, such as multi-valent vaccines and oral administration options, have further increased demand. These developments make vaccines more effective and convenient, ensuring higher adoption rates.
• Government Campaigns: Government-led vaccination initiatives, particularly in emerging economies, have boosted dog vaccine sales. These campaigns help manage diseases like rabies, contributing to market expansion.
• Expanding Veterinary Infrastructure: The expansion of veterinary services and facilities, particularly in emerging markets, is facilitating greater access to dog vaccines. Improved veterinary infrastructure ensures that more pets receive timely vaccinations, supporting overall market growth.

Challenges in the dog vaccine market include:

• Financial Constraints: Economic issues, such as the cost of manufacturing vaccines and their affordability, can cause fluctuations within this market segment. It is imperative to balance cost and quality to remain competitive while expanding.
• Regulatory Hurdles: Compliance with strict regulations regarding vaccine approval and safety can be challenging. Meeting these requirements is essential for gaining access to target markets and developing products, which can delay processes and increase costs.
• Reluctance Toward Vaccination: Pet owners' hesitancy toward vaccinations poses a barrier to growth in this industry. Addressing concerns about vaccine safety and effectiveness can significantly raise immunization coverage and expand the overall market.

These drivers and challenges define product development, market growth, and regulatory compliance, thereby shaping the dog vaccine market.

List of Dog Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies dog vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the dog vaccine companies profiled in this report include-

• Bayer
• Vetquinol
• Boehringer Ingelhiem
• Ceva
• Eli Lilly
• Heska
• Merck

Dog Vaccine by Segment

The study includes a forecast for the global dog vaccine market by type, age, end use, and region.

Dog Vaccine Market by Type [Analysis by Value from 2019 to 2031]:

• Attenuated Live Vaccines
• Conjugate Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• Toxoid Vaccines
• DNA Vaccines
• Recombinant Vaccine

Dog Vaccine Market by Age [Analysis by Value from 2019 to 2031]:

• Below 6 Months
• Above 6 Months

Dog Vaccine Market by End Use [Analysis by Value from 2019 to 2031]:

• Veterinary Hospitals & Clinics
• Pet Owners
• Others

Dog Vaccine Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Dog Vaccine Market

Improvements in pet ownership, growing awareness of dog health, and technological advancements are contributing to significant progress in the dog vaccine sector. Vaccine formulations, distribution channels, and government initiatives guiding dog vaccination rates and general pet healthcare are undergoing notable changes in key markets such as the US, China, Germany, India, and Japan.

• United States: There is increased demand for multi-valent dog vaccines that protect against multiple diseases, reducing the number of injections required. Additionally, digital platforms are being adopted to enhance vaccine distribution and monitoring, thus improving overall vaccination compliance rates and coverage.
• China: China is experiencing rapid growth in the dog vaccine market due to its expanding middle class, resulting in a higher number of pets owned per household. The government has launched various campaigns aimed at controlling rabies and other diseases, while local manufacturers are diversifying their product range to meet rising demands.
• Germany: Research activities targeting new canine diseases are prevalent in Germany. The country has also tightened quality control requirements to ensure that all newly developed vaccines meet high standards before being sold.
• India: The Indian dog vaccine market is growing due to the introduction of low-cost vaccines, particularly for rural communities. Government initiatives are facilitating widespread rabies vaccinations, while private sector players are entering vaccine manufacturing and distribution to meet current needs.
• Japan: Japan has advanced in creating innovative vaccine forms, including oral vaccines, which simplify the vaccination process for pet owners. Furthermore, the nation has improved its regulatory framework regarding safe and effective vaccine development, supporting a rise in preventive pet healthcare.

Features of the Global Dog Vaccine Market

Market Size Estimates: Dog vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Dog vaccine market size by type, age, end use, and region in terms of value ($B).

Regional Analysis: Dog vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, ages, end uses, and regions for the dog vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the dog vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the dog vaccine market by type (attenuated live vaccines, conjugate vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, DNA vaccines, and recombinant vaccine), age (below 6 months and above 6 months), end use (veterinary hospitals & clinics, pet owners, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Dog Vaccine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Dog Vaccine Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Dog Vaccine Market by Type
  • 3.3.1: Attenuated Live Vaccines
  • 3.3.2: Conjugate Vaccines
  • 3.3.3: Inactivated Vaccines
  • 3.3.4: Subunit Vaccines
  • 3.3.5: Toxoid Vaccines
  • 3.3.6: DNA Vaccines
  • 3.3.7: Recombinant Vaccine
• 3.4: Global Dog Vaccine Market by Age
  • 3.4.1: Below 6 months
  • 3.4.2: Above 6 months
• 3.5: Global Dog Vaccine Market by End Use
  • 3.5.1: Veterinary Hospitals & Clinics
  • 3.5.2: Pet Owners
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Dog Vaccine Market by Region
• 4.2: North American Dog Vaccine Market
  • 4.2.1: North American Market by Type: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccine
  • 4.2.2: North American Market by End Use: Veterinary Hospitals & Clinics, Pet Owners, and Others
• 4.3: European Dog Vaccine Market
  • 4.3.1: European Market by Type: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccine
  • 4.3.2: European Market by End Use: Veterinary Hospitals & Clinics, Pet Owners, and Others
• 4.4: APAC Dog Vaccine Market
  • 4.4.1: APAC Market by Type: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccine
  • 4.4.2: APAC Market by End Use: Veterinary Hospitals & Clinics, Pet Owners, and Others
• 4.5: ROW Dog Vaccine Market
  • 4.5.1: ROW Market by Type: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccine
  • 4.5.2: ROW Market by End Use: Veterinary Hospitals & Clinics, Pet Owners, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Dog Vaccine Market by Type
  • 6.1.2: Growth Opportunities for the Global Dog Vaccine Market by Age
  • 6.1.3: Growth Opportunities for the Global Dog Vaccine Market by End Use
  • 6.1.4: Growth Opportunities for the Global Dog Vaccine Market by Region
• 6.2: Emerging Trends in the Global Dog Vaccine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Dog Vaccine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Dog Vaccine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Bayer
• 7.2: Vetquinol
• 7.3: Boehringer Ingelhiem
• 7.4: Ceva
• 7.5: Eli Lilly
• 7.6: Heska
• 7.7: Merck